/ EN

Mobile

Shandong LINUO Pharmaceutical Co., Ltd.
ADD:Ji'nan No. ten East Road 30766 Connaught Technology Park
MAP>>

Business advisory telephone:0531-88729642

E-MAIL:lnyybgs@lnphar.com

WeChat

In April 2018, Linuo Pharma and Beijing Sun-Novo Pharmaceutical Research Co.,Ltd. signed a strategic cooperation agreement on dr

Release time:
2018/09/25
Page view
[Abstract]:
In April 2018, Linuo Pharma and Beijing Sun-Novo Pharmaceutical Research Co.,Ltd. signed a strategic cooperation agreement on drug R&D in Beijing. The two sides have fully cooperated in technical cons
   In April 2018 , Linuo Pharma and Beijing Sun-Novo Pharmaceutical Research Co. ,Ltd. signed a strategic cooperation agreement on drug R&D in Beijing. The two sides have fully cooperated in technical consultation, commissioned R&D, joint R&D,   and listing license holders.  Nine products were screened and initially identified for  the central nervous system, cardio-cerebrovascular and hypoglycemic drugs.
 
    Beijing Sun-Novo is a national high-tech enterprise  which  integrates generic pharmacy and clinical research, raw materials and  preparations . It has passed the  ISO 9001:2008 quality management system certification. It is the first-class generic pharmaceutical R&D enterprise in Beijing  and scientific   and technological research   and development institutions.
 
   In June 2018 , the two sides identified 9 generic drug development  contracts  to  start the research and development of  generic   drugs . Beijing Sun-Novo  and the 2  generic drugs listed on the market are officially settled in 2019.